CHARACTERIZATION OF THE BUPROPION CUE IN THE RAT - LACK OF EVIDENCE FOR A DOPAMINERGIC MECHANISM

被引:24
作者
BLITZER, RD
BECKER, RE
机构
[1] UNIV RHODE ISL,DEPT PHARMACOL,KINGSTON,RI 02881
[2] SO ILLINOIS UNIV,SCH MED,DEPT PSYCHIAT,SPRINGFIELD,IL 62708
关键词
D O I
10.1007/BF00428409
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:173 / 177
页数:5
相关论文
共 28 条
[1]  
BECKER RE, 1982, AM J PSYCHIAT, V139, P1200
[3]  
BUTZ RF, 1982, J PHARMACOL EXP THER, V221, P676
[4]  
CANNING H, 1979, BRIT J PHARMACOL, V66, pP104
[5]  
CHARNEY DS, 1981, ARCH GEN PSYCHIAT, V38, P1160
[6]   EVIDENCE THAT A PREFERRED SUBSTRATE FOR TYPE-B MONOAMINE-OXIDASE MEDIATES STIMULUS PROPERTIES OF MAO INHIBITORS - A POSSIBLE ROLE FOR BETA-PHENYLETHYLAMINE IN THE COCAINE CUE [J].
COLPAERT, FC ;
NIEMEGEERS, CJE ;
JANSSEN, PAJ .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1980, 13 (04) :513-517
[7]  
COOPER BR, 1980, J PHARMACOL EXP THER, V215, P127
[8]  
FANN WE, 1978, CURR THER RES CLIN E, V23, P222
[9]  
FERRIS RM, 1978, FED PROC, V37, P481
[10]   SOME NEUROCHEMICAL PROPERTIES OF A NEW ANTI-DEPRESSANT, BUPROPION HYDROCHLORIDE (WELLBUTRIN) [J].
FERRIS, RM ;
WHITE, HL ;
COOPER, BR ;
MAXWELL, RA ;
TANG, FLM ;
BEAMAN, OJ ;
RUSSELL, A .
DRUG DEVELOPMENT RESEARCH, 1981, 1 (01) :21-35